Jack Khattar is Chief Executive Officer, President & Secretary of Supernus Pharmaceuticals, Inc. (SUPN). The company reported total compensation of $15,501,557 for fiscal year 2025.
| Salary | $1,036,000 |
|---|---|
| Bonus | $0 |
| Stock awards | $6,535,029 |
| Option awards | $7,031,545 |
| Non-equity incentive plan | $846,930 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $52,053 |
| Total | $15,501,557 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Supernus Pharmaceuticals, Inc. filed April 30, 2026, accession 0001104659-26-053111.
| Fiscal year | Role | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension / NQDC | All other | Total |
|---|---|---|---|---|---|---|---|---|---|
| FY2025 | Chief Executive Officer, President & Secretary | $1,036,000 | $0 | $6,535,029 | $7,031,545 | $846,930 | $0 | $52,053 | $15,501,557 |
| FY2024 | Chief Executive Officer, President & Secretary | $1,001,500 | — | $5,199,012 | $5,567,427 | $826,254 | — | $46,796 | $12,640,989 |
| FY2023 | Chief Executive Officer, President & Secretary | $963,000 | $0 | $4,760,000 | $6,675,200 | $830,588 | $0 | $49,305 | $13,278,093 |
Totals as disclosed in each year's own compensation disclosure for Supernus Pharmaceuticals, Inc..
| Peer-group chief executive median | $8,526,943 |
|---|---|
| Difference from that median | $6,974,614 |
| Percentile within the disclosed peer group | 93rd |
| Peers with a disclosed figure | 15 |
Medians and percentiles are computed across the peer group Supernus Pharmaceuticals, Inc. discloses in its own compensation disclosure.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| Jack Khattar this page | Chief Executive Officer, President & Secretary | $15,501,557 |
| Timothy Dec | Senior Vice President, Chief Financial Officer | $1,916,409 |
| Jonathan Rubin | Senior Vice President, Chief Medical Officer, Research and Development | $1,448,731 |
| Padmanabh Bhatt | Senior Vice President of Intellectual Property, Chief Scientific Officer | $1,391,429 |
| Frank Mottola | Senior Vice President, Chief Technical Operations Officer | $1,360,701 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Supernus Pharmaceuticals, Inc. compensation brief.
Jack Khattar's compensation sits inside Supernus Pharmaceuticals, Inc.'s full executive and board picture — the peer group, pay against peers, incentive design and the board itself.
The Supernus Pharmaceuticals, Inc. (SUPN) compensation brief